All In Biotech

Free tool

FAERS Monitor: Brethine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017849 or its brand name (Brethine, Terbutaline Sulfate). Reports on generic versions are filed under their own applications.

Reports

1,839

Serious

1,762

96% of reports

Hospitalization

878

Death reported

169

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea426
  • asthma380
  • wheezing258
  • pneumonia209
  • cough206
  • drug ineffective153
  • fatigue148
  • loss of personal independence in daily activities142
  • therapeutic product effect incomplete124
  • sleep disorder due to a general medical condition120
  • nasopharyngitis112
  • malaise108
  • dizziness104
  • vomiting103
  • blood pressure increased102

Reports by year received

View as table
YearReports
200463
200557
200651
200783
200877
200981
201077
201159
201218
201331
201428
201532
201625
201749
201854
2019111
2020149
2021183
2022189
2023138
2024119
202587
202678

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,320 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sleep disorder due to a general medical conditionSignal12081.468.49,388
wheezingSignal25850.044.612,314
asthmaSignal38038.635.313,902
loss of personal independence in daily activitiesSignal14233.928.94,499
therapeutic product effect incompleteSignal12420.016.82,219
dyspnoeaSignal4268.67.92,936
coughSignal2068.47.41,354
blood pressure increasedSignal1027.66.3585
pneumoniaSignal2097.46.51,165
nasopharyngitisSignal1127.05.8570
malaiseSignal1082.82.3127
vomitingSignal1032.52.194
dizzinessSignal1042.42.084
fatigueSignal1482.21.996
drug ineffective1531.31.113

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.